Ryan & Maniskas, LLP Announces Investigation of Complete Genomics, Inc.
September 18 2012 - 10:34AM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/gnom) is
investigating potential claims against the board of directors of
Complete Genomics, Inc. (“Complete Genomics” or the “Company”)
(NASDAQ: GNOM) concerning possible breaches of fiduciary duty and
other violations of law related to the Company’s efforts to sell
the Company to BGI-Shenzhen in an all-cash deal valued at
approximately $117.6 million.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to the approval of the
transaction by the Company’s board of directors; in particular,
whether the Company undertook a fair process to obtain fair
consideration for all shareholders of Complete Genomics. For more
information regarding our investigation, please contact Ryan &
Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877)
316-3218 or by email at rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/gnom.
Under the terms of the proposed transaction, Complete Genomics
stockholders will receive $3.15 in cash for each share of Complete
Genomics common stock they own.
If you own shares of Complete Genomics and would like to learn
more about these claims or if you wish to discuss these matters and
have any questions concerning this announcement or your rights,
contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or
to sign up online, visit: www.rmclasslaw.com/cases/gnom. You may
also email Mr. Maniskas at rmaniskas@rmclasslaw.com. For more
information about class action cases in general, please visit our
website: www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide.
Global X Genomics and Bi... (NASDAQ:GNOM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Global X Genomics and Bi... (NASDAQ:GNOM)
Historical Stock Chart
From Jul 2023 to Jul 2024